Wang Chin-Man, Chang Su-Wei, Wu Yeong-Jian Jan, Lin Jing-Chi, Ho Huei-Huang, Chou Tse-Chih, Yang Bing, Wu Jianming, Chen Ji-Yih
1] Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, No. 5, Fu-Shin St. Kwei-Shan, Tao-Yuan, 33375 Taiwan [2].
1] Clinical Informatics and Medical Statistics Research Center, Chang Gung University, College of Medicine, 259 Wenhua 1st Road, Kwei-Shan, Tao-Yuan, 33375 Taiwan [2].
Sci Rep. 2014 Jan 21;4:3792. doi: 10.1038/srep03792.
Toll-like receptors (TLRs), as innate immunity sensors, play critical roles in immune responses. Six SNPs of TLR3, TLR7, and TLR8 were genotyped to determine their associations with systemic lupus erythematosus (SLE) and clinical manifestations of SLE. TLR7 SNP rs3853839 was independently associated with SLE susceptibility in females (G vs. C: p = 0.0051). TLR7 rs3853839-G (G vs. C: p = 0.0100) and TLR8 rs3764880-G (recessive model: p = 0.0173; additive model: p = 0.0161) were associated with pericardial effusion in females relative to healthy females. Anti-SSA positive cases were more likely to have the dominant TLR7 rs179010-T allele than normal controls (p = 0.0435). TLR3 rs3775296-T was associated with photosensitivity (p = 0.0020) and anemia (p = 0.0082). The "G-G" haplotype of TLR7 rs3853839 and TLR8 rs3764880 increased risk of SLE in females (age adjusted p = 0.0032). These findings suggest that TLR variations that modify gene expression affect risk for SLE susceptibility, clinical phenotype development, and production of autoantibodies.
Toll样受体(TLR)作为天然免疫传感器,在免疫反应中发挥关键作用。对TLR3、TLR7和TLR8的6个单核苷酸多态性(SNP)进行基因分型,以确定它们与系统性红斑狼疮(SLE)及其临床表现的关联。TLR7 SNP rs3853839与女性SLE易感性独立相关(G与C比较:p = 0.0051)。相对于健康女性,TLR7 rs3853839 - G(G与C比较:p = 0.0100)和TLR8 rs3764880 - G(隐性模型:p = 0.0173;加性模型:p = 0.0161)与女性心包积液相关。抗SSA阳性病例比正常对照更有可能具有显性TLR7 rs179010 - T等位基因(p = 0.0435)。TLR3 rs3775296 - T与光敏性(p = 0.0020)和贫血(p = 0.0082)相关。TLR7 rs3853839和TLR8 rs3764880的“G - G”单倍型增加了女性患SLE的风险(年龄校正p = 0.0032)。这些发现表明,改变基因表达的TLR变异会影响SLE易感性、临床表型发展和自身抗体产生的风险。